Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

Published:2013-02-06 Issue:1 Volume:34 Page:1-114
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Froestl Wolfgang¹,Pfeifer Andrea¹,Muhs Andreas¹

Affiliation:

1. AC Immune SA, EPFL, Lausanne, Switzerland

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond stroke therapy, neuroaid (a chinese herbal) has an effect on cognition and neurogenesis, a bibliometric study;F1000Research;2024-07-16

2. Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2;Cancer Discovery;2024-04-01

3. Current Trends in the Animal Models for Screening of Nootropic Agents: A Systematic Review;Current Reviews in Clinical and Experimental Pharmacology;2023-11

4. Modern synthesis of cognitive enhancers: cholinergic ligands;Russian Chemical Bulletin;2023-04

5. L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke;Pharmacological Reports;2023-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP